Published in Br J Cancer on November 01, 1999
Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J Natl Cancer Inst (2010) 1.74
A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS One (2013) 1.50
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin Exp Metastasis (2008) 1.25
Nox-4-dependent nuclear H2O2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation. Antioxid Redox Signal (2010) 1.05
Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo. Neoplasia (2009) 1.03
Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production. PLoS One (2011) 1.01
Predictive value of preoperative serum CCL2, CCL18, and VEGF for the patients with gastric cancer. BMC Clin Pathol (2013) 0.94
Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice. BMC Immunol (2011) 0.94
Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma. Chin J Cancer (2015) 0.93
Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma. PLoS One (2013) 0.91
Oral administration of blueberry inhibits angiogenic tumor growth and enhances survival of mice with endothelial cell neoplasm. Antioxid Redox Signal (2009) 0.90
Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis. PLoS One (2012) 0.89
Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma. J Cancer Res Clin Oncol (2005) 0.86
Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course. Oncoimmunology (2015) 0.83
Serum monocyte chemoattractant protein-1 in pancreatic cancer. J Oncol (2011) 0.81
Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget (2016) 0.81
Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis. Int J Clin Exp Pathol (2014) 0.78
Plasma monocyte chemotactic protein-1 remains elevated after minimally invasive colorectal cancer resection. World J Gastrointest Oncol (2014) 0.76
Role of Monocyte Count and Neutrophil-to-Lymphocyte Ratio in Survival of Oral Cancer Patients. Int Arch Otorhinolaryngol (2016) 0.75
Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform. Clin Biochem (2015) 0.75
Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia. Int J Mol Sci (2016) 0.75
The role of macrophages in bone metastasis. J Bone Oncol (2013) 0.75
Early inflammatory response in epithelial ovarian tumor cyst fluids. Cancer Med (2014) 0.75
Magnetically-actuated, bead-enhanced silicon photonic immunosensor. Anal Methods (2015) 0.75
Biology of the RANTES/SIS cytokine family. Cytokine (1991) 3.97
Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today (1990) 3.31
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest (1995) 1.91
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol (1997) 1.79
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol Res Pract (1998) 1.60
Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest (1994) 1.43
Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol (1996) 1.39
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer (1994) 1.25
Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material. Br J Cancer (1982) 1.17
Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol (1992) 1.17
Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases. J Immunol (1984) 1.16
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. Am J Pathol (1996) 1.12
Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer. Br J Urol (1998) 1.07
Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors. J Leukoc Biol (1998) 1.00
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J Natl Cancer Inst (1993) 1.00
Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells. Cancer Res (1997) 0.90
Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages. Int J Cancer (1991) 0.87
An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int J Cancer (1995) 0.85
Prognostic significance of morphology of tumor and retroperitoneal lymph nodes in epithelial carcinoma of the ovary. II. Correlation with survival. Gynecol Oncol (1984) 0.84
Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res (2000) 3.35
Geography of biomedical publications in the European Union, 1990-98. Lancet (1999) 3.02
Limitations of the transpulmonary indicator dilution method for assessment of preload changes in critically ill patients with reduced left ventricular function. Crit Care Med (2000) 2.10
Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res (2001) 1.99
Fractal analysis: an objective method for identifying atypical nuclei in dysplastic lesions of the cervix uteri. Gynecol Oncol (1999) 1.74
Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med (2000) 1.66
Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. Am J Clin Pathol (1996) 1.60
Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis. Br J Obstet Gynaecol (1997) 1.59
Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients. Int J Cancer (2001) 1.58
Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma? J Clin Endocrinol Metab (2005) 1.51
Whole blood viscosity, plasma viscosity and erythrocyte aggregation in nine mammalian species: reference values and comparison of data. Exp Physiol (2003) 1.44
Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy. Gynecol Oncol (1997) 1.42
MMP-1 and MMP-2 expression in uterine leiomyosarcoma and correlation with different clinicopathologic parameters. J Soc Gynecol Investig (2003) 1.40
Fourteen-year experience with laparoscopic ventrosuspension in patients with retroverted and retroflected uterus and pelvic pain syndromes. J Minim Invasive Gynecol (2010) 1.39
Hysteroscopy in 2001: a comprehensive review. Acta Obstet Gynecol Scand (2001) 1.39
Prolongation of pregnancy and survival of twin B after loss of twin A at 21 weeks' gestation. Am J Obstet Gynecol (1989) 1.39
[Human papillomavirus infections and carcinoembryonic antigen expression in cervix intra-epithelial neoplasia of intermediate grade]. Pathologe (1993) 1.37
Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol (1999) 1.34
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol (2001) 1.33
Serum concentration of pregnancy-specific beta-1-glycoprotein (sp-1) in normal and pathologic pregnancies. Arch Gynakol (1974) 1.30
Serum evaluation of interleukin 6 in ovarian cancer patients. Gynecol Oncol (1997) 1.30
Analgesic and hemodynamic effects of intrathecal clonidine as the sole analgesic agent during first stage of labor: a dose-response study. Anesthesiology (1999) 1.25
Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates. Infect Immun (1999) 1.24
Leiomyoma in the space of Retzius: a report of 2 cases. Am J Obstet Gynecol (2001) 1.22
Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer (2001) 1.21
The impact of lymph node density on survival of cervical cancer patients. Br J Cancer (2010) 1.21
Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol (1995) 1.17
Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial. Br J Cancer (2000) 1.17
Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. Clin Cancer Res (2001) 1.17
Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival. Int J Cancer (1997) 1.16
Association between endometrial cancer and tamoxifen treatment of breast cancer. Breast Cancer Res Treat (1999) 1.16
The standard Gamma nail: a critical analysis of 1,000 cases. J Trauma (2001) 1.15
Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines. Breast Cancer Res Treat (1999) 1.15
Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci. Med Microbiol Immunol (1997) 1.15
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial. Br J Cancer (2010) 1.14
Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol (1998) 1.13
A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial. Eur J Obstet Gynecol Reprod Biol (1988) 1.13
Influence of acupuncture on maternal serum levels of interleukin-8, prostaglandin F2alpha, and beta-endorphin: a matched pair study. Obstet Gynecol (1998) 1.12
Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy. Br J Cancer (1996) 1.07
Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria. Wien Klin Wochenschr (1999) 1.07
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis. Cancer Treat Rev (2015) 1.05
Impact of epoetin beta on quality of life in patients with malignant disease. Br J Cancer (2003) 1.04
[Pregnancy-specific beta1-glycoprotein (sp-1): clinical aspects (author's transl)]. Wien Klin Wochenschr (1975) 1.04
Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison. Anticancer Res (1999) 1.03
Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Hum Reprod (2005) 1.02
Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother (2000) 1.02
Nosocomial outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography. Clin Microbiol Infect (2010) 1.02
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients. Gynecol Oncol (2000) 1.02
Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer. Anticancer Res (2002) 1.01
Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst (1997) 1.01
Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial. Br J Cancer (2012) 1.01
Nomogram prediction for overall survival of patients diagnosed with cervical cancer. Br J Cancer (2012) 1.01
Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br J Cancer (1995) 1.00
The role of intra-abdominal pressure on splanchnic and pulmonary hemodynamic and metabolic changes during carbon dioxide pneumoperitoneum. Gastrointest Endosc (1999) 0.99
Small-cell carcinoma of the uterus and the vagina: experience with ten patients. Arch Gynecol Obstet (2004) 0.98
Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature. Gynecol Oncol (1998) 0.98
Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut (1997) 0.98
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway. Br J Cancer (2007) 0.98
Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol (2002) 0.97
Changes of serum chloride and metabolic acid-base state in critical illness. Anaesthesia (2004) 0.96
Modulation of IgA, IgE, and IgG Fc receptor expression on human mononuclear phagocytes by 1 alpha,25-dihydroxyvitamin D3 and cytokines. J Leukoc Biol (1995) 0.96
Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer. Br J Cancer (2013) 0.96
IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: effects of IL-10 and other cytokines on cell phenotype and phagocytosis. Immunology (1995) 0.95
Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res (1995) 0.95
Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer. Gynecol Oncol (1989) 0.95
Anti-CD2 and anti-CD3 induced T cell cytotoxicity of human intraepithelial and lamina propria lymphocytes. Gut (1992) 0.95
Influence of glutamine on the phenotype and function of human monocytes. Blood (1995) 0.94
Serum evaluation of basic FGF in breast cancer patients. Anticancer Res (1996) 0.94
Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer (1995) 0.94
Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study. Breast Cancer Res Treat (2001) 0.94
Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection. Gynecol Oncol (1999) 0.93